description | Optune Lua® concurrent with PD-1/PD-L1 inhibitor or docetaxel is FDA-approved for adult patients with metastatic non–small cell lung cancer (mNSCLC) who have progressed on or after a platinum- based regimen. |
introduction |
www.optuneluahcp.com There are 3 links were found on the page. There are 1 backlinks link to www.optuneluahcp.com There are 1 anchor text link to www.optuneluahcp.com,the most used anchor text in all backlinks is: .css-8g8ihq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;gap:0.5rem;}For Healthcare Professionals |
update time | 2025-09-19 22:19:53 |
type: text
text: Visit Patient Site
link: www.optunelua.com
behavior: follow
type: text
text: .css-17uz99v{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;gap:6p
link: www.optunegiohcp.com
behavior: follow
type: text
text: Novocuretrials.com
link: www.novocuretrials.com
behavior: follow
site: www.optunelua.com
type: text
text: .css-8g8ihq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;gap:0.5rem;}For Healthcare Professionals
link: www.optuneluahcp.com
behavior: follow